Modernatx.com

Moderna Achieves Positive Interim Results from Phase …

WEBCAMBRIDGE, MA / ACCESSWIRE / March 26, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced that mRNA-1283, the Company's next-generation COVID-19 vaccine, …

Actived: 9 days ago

URL: https://news.modernatx.com/news/news-details/2024/Moderna-Achieves-Positive-Interim-Results-from-Phase-3-Trial-of-Next-Generation-COVID-19-Vaccine/default.aspx

Moderna Advances Multiple Vaccine Programs to Late-Stage …

WEBAnnounces next-generation COVID-19 vaccine candidate as fourth respiratory vaccine to successfully meet its Phase 3 endpoints Expects two more Phase 3 readouts in 2024, …

Category:  Health Go Health

Investigational mRNA Vaccines & Respiratory Syncytial Virus

WEBToday we announced positive top-line data from our pivotal Phase 3 study of mRNA-1345, our investigational vaccine candidate against respiratory syncytial virus (RSV), in older …

Category:  Health Go Health

Moderna Announces Clinical and Program Updates at 3rd Annual …

WEBCOVID-19 vaccine Phase 2/3 study in children 6 months to under 6 years has successfully met its primary endpoint with robust neutralizing antibody titers similar to adults. …

Category:  Health Go Health

Pioneering mRNA technology

WEBLearn how we’re changing the world of medicine. Discover career opportunities, our product pipeline, and browse media resources. Meet Moderna.

Category:  Medicine Go Health

Moderna Announces Its Global Public Health Strategy

WEBModerna announces commitment to advance vaccines targeting 15 pathogens identified as biggest public health risk by WHO and CEPI into clinical studies by 2025 Moderna …

Category:  Health Go Health

Moderna Announces First Participant Dosed in Phase 3 Study of …

WEBmRNA-1083 is Moderna's first respiratory combination vaccine candidate to enter a Phase 3 trial Phase 3 initiation follows data from a Phase 1/2 trial where mRNA-1083 showed …

Category:  Health Go Health

Celebrating the 10th Anniversary of Health Conference

WEB2022 marks the 10th anniversary of the mRNA Health Conference, jointly organized by Moderna, BioNTech and CureVac, the only annual conference dedicated solely to …

Category:  Health Go Health

Moderna Expands the Field of mRNA Medicine with Positive …

WEBCompany's flu vaccine, mRNA-1010, met its primary endpoint in Phase 3 trial; separate Phase 1/2 data demonstrated higher HAI titers than Fluzone HD Vaccine pipeline …

Category:  Health Go Health

Removing Barriers to Representation in Clinical Research

WEBAt Moderna, our approach to increasing representation in clinical research is grounded in lessons learned and in our values as a company. The last few years have amplified the …

Category:  Health Go Health

Moderna Announces mRNA-1345, an Investigational Respiratory …

WEBmRNA-1345 demonstrated vaccine efficacy of 83.7% against RSV lower respiratory tract disease, defined by 2 or more symptoms in older adults mRNA-1345 was generally well …

Category:  Health Go Health

Moderna Announces Changes to Commercial Organization to …

WEBCAMBRIDGE, MA / ACCESSWIRE / December 12, 2023 / Moderna, Inc. (NASDAQ:MRNA) today announced changes to its operating model to bring focus to its short- and long …

Category:  Health Go Health

Moderna’s Commitment to Patient Access in the United States

WEBModerna’s vaccines have protected the lives of hundreds of millions of people around the world from COVID-19 and have dramatically lessened the burden of the pandemic to …

Category:  Health Go Health

Moderna Charitable Foundation – Moderna

WEBOur company launched the Moderna Charitable Foundation in 2022 to support organizations and causes that promote public health and access to quality healthcare, …

Category:  Health Go Health

Moderna Shares Environmental, Social and Governance Highlights …

WEBModerna continues development of at least 15 vaccine programs targeting emerging or neglected infectious diseases by 2025 as part of global health program Moderna is …

Category:  Health Go Health

Moderna Reviews its Environmental, Social and Governance (ESG) …

WEBThe Company's ESG strategy demonstrates its efforts to advance global health and environmental sustainability, as well as its commitments to employees and communities …

Category:  Health Go Health

ESG Progress: Impacting Health & Sustainability

WEBEarlier this year, we evolved our mission to better reflect our belief that Moderna’s mRNA medicines will continue to have a profound impact on human health. We are working to …

Category:  Medicine Go Health

Moderna Provides Business and Pipeline Updates at 42nd Annual …

WEBJamey Mock, Chief Financial Officer of Moderna, will present an update on the Company and its pipeline of mRNA development programs on Monday, January 8 th, 2024, at 3:45 …

Category:  Health Go Health

Moderna to Present at the 42nd Annual J.P. Morgan Healthcare …

WEBCAMBRIDGE, MA / ACCESSWIRE / December 20, 2023 / Moderna, Inc. (Nasdaq:MRNA), today announced that Jamey Mock, Chief Financial Officer, will present at the 42nd …

Category:  Health Go Health